Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

NCT02808403 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2024-11-21

No results posted yet for this study

Summary

The purpose of this post-marketing survey is to obtain real-world information on the safety and effectiveness of evolocumab in Japan.

Conditions

Interventions

OTHER

No intervention

No intervention; observation of routine medical care

Sponsors & Collaborators

Principal Investigators

  • MD · Amgen

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-24
Primary Completion
2022-10-31
Completion
2023-03-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02808403 on ClinicalTrials.gov